True, but also tells me the shorts are not shortin
Post# of 148373
Also suggests there are buyers willing to grab the low scraps
To offer in a valuation and buyouts...I think $10 is a pathetically low price, a steal attempt, and would hope the Board would reject it as would shareholders if offered a vote. I agree with Kelly's comment that CYDY will be an oncology company and that valuation has to be $50++ bare minimum. Plus NASH, HIV mono and who knows about potential Alzheimers and other diseases where the brain is involved. I think Covid treatment would be a nice cash flow but not the basis on which the company would be valued. (Did I cover all 29 on Ohms list?) I always felt $25 was a decent number to cash out, just on a personal note, although I feel $50 is very much in the cards and triple digits are a possibility (would need more time). But these are all exciting numbers. This is an exciting moment in CYDY's history.
To The Moon Alice